Since the two sorted RCC52 subsets were relatively tumorigenic in NOD/SCID mice with the CD44bright/CD24bright fibroblastoid subset yielding a greater tumorogenicity, as demonstrated above, we hypothesized that the RCC CSC marker CD105 should be expressed by both subsets. Here, ENG is linked to renal cell carcinoma.